PseudoprotodioscinCAS# 102115-79-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 102115-79-7 | SDF | Download SDF |
| PubChem ID | 51346147 | Appearance | Powder |
| Formula | C51H82O2 | M.Wt | 727.2 |
| Type of Compound | Steroids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(1S,2S,4S,8S,9S,12S,13R)-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,18-dien-16-yl]oxy]oxan-3-yl]oxy-6-methyloxane-3,4,5-triol | ||
| SMILES | CC1C(C(C(C(O1)OC2C(OC(C(C2O)OC3C(C(C(C(O3)C)O)O)O)OC4CCC5(C6CCC7(C(C6CC=C5C4)CC8C7C(=C(O8)CCC(C)COC9C(C(C(C(O9)CO)O)O)O)C)C)C)CO)O)O)O | ||
| Standard InChIKey | MDCUMTGKKLOMCW-MQDUZHDNSA-N | ||
| Standard InChI | InChI=1S/C51H82O21/c1-20(19-64-46-40(60)39(59)36(56)31(17-52)69-46)7-10-29-21(2)33-30(68-29)16-28-26-9-8-24-15-25(11-13-50(24,5)27(26)12-14-51(28,33)6)67-49-45(72-48-42(62)38(58)35(55)23(4)66-48)43(63)44(32(18-53)70-49)71-47-41(61)37(57)34(54)22(3)65-47/h8,20,22-23,25-28,30-49,52-63H,7,9-19H2,1-6H3/t20-,22+,23+,25?,26-,27+,28+,30+,31-,32-,33+,34+,35+,36-,37-,38-,39+,40-,41-,42-,43+,44-,45-,46-,47+,48+,49-,50+,51+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Pseudoprotodioscin exhibits anti-inflammatory and anticancer activities, it shows a weaker suppressing effect on the production of inflammatory cytokines, and can suppress melanogenesis in B16F1 cells. |
| Targets | Immunology & Inflammation related |
| In vitro | Anti-inflammatory and anti-melanogenic steroidal saponin glycosides from Fenugreek (Trigonella foenum-graecum L.) seeds.[Pubmed: 20979021 ]Planta Med. 2011 May;77(7):705-10.Fenugreek seed ( Trigonella foenum-graecum L.) is used as an herbal medicine for treating metabolic and nutritive dysfunctions. Two new steroidal saponins from the rhizomes of Dioscorea panthaica and their cytotoxic activity.[Pubmed: 11745024]Planta Med. 2001 Dec;67(9):853-7.Two new steroidal saponins, dioscoresides C (1) and D (2), along with a new natural product, pregnadienolone 3-O-beta-gracillimatriose (3), and two known compounds, pregnadienolone 3-O-beta-chacotrioside (4) and Pseudoprotodioscin (5), were isolated from the rhizomes of Dioscorea panthaica Prain et Burkill. |
Pseudoprotodioscin Dilution Calculator
Pseudoprotodioscin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3751 mL | 6.8757 mL | 13.7514 mL | 27.5028 mL | 34.3784 mL |
| 5 mM | 0.275 mL | 1.3751 mL | 2.7503 mL | 5.5006 mL | 6.8757 mL |
| 10 mM | 0.1375 mL | 0.6876 mL | 1.3751 mL | 2.7503 mL | 3.4378 mL |
| 50 mM | 0.0275 mL | 0.1375 mL | 0.275 mL | 0.5501 mL | 0.6876 mL |
| 100 mM | 0.0138 mL | 0.0688 mL | 0.1375 mL | 0.275 mL | 0.3438 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Pseudoproto Pb
Catalog No.:BCN2838
CAS No.:102100-46-9
- 3-(4-Hydroxyphenyl)-1-propanol
Catalog No.:BCN5836
CAS No.:10210-17-0
- Boc-D-Phenylglycinol
Catalog No.:BCC2711
CAS No.:102089-74-7
- Sappanone A
Catalog No.:BCN2996
CAS No.:102067-84-5
- Arctinol B
Catalog No.:BCN5835
CAS No.:102054-39-7
- 3-Deazaneplanocin,DZNep
Catalog No.:BCC1129
CAS No.:102052-95-9
- Tubeimoside I
Catalog No.:BCN1089
CAS No.:102040-03-9
- Protosappanin B
Catalog No.:BCN2281
CAS No.:102036-29-3
- Protosappanin A
Catalog No.:BCN7259
CAS No.:102036-28-2
- PF-04457845
Catalog No.:BCC1851
CAS No.:1020315-31-4
- (R)-4-Benzyl-2-oxazolidinone
Catalog No.:BCC8395
CAS No.:102029-44-7
- DCC-2036 (Rebastinib)
Catalog No.:BCC4390
CAS No.:1020172-07-9
- Cyclocytidine HCl
Catalog No.:BCC5555
CAS No.:10212-25-6
- rac-Rotigotine Hydrochloride
Catalog No.:BCC1881
CAS No.:102120-99-0
- AM580
Catalog No.:BCC5373
CAS No.:102121-60-8
- Atractylic acid dipotassium salt
Catalog No.:BCN5384
CAS No.:102130-43-8
- Isoprocurcumenol
Catalog No.:BCN3528
CAS No.:102130-90-5
- Neoprocurcumenol
Catalog No.:BCN3694
CAS No.:102130-91-6
- RJR 2429 dihydrochloride
Catalog No.:BCC7000
CAS No.:1021418-53-0
- DPCPX
Catalog No.:BCC6649
CAS No.:102146-07-6
- Boc-D-Pro-OSu
Catalog No.:BCC3438
CAS No.:102185-34-2
- Boc-Arg(Mts)-OH
Catalog No.:BCC3054
CAS No.:102185-38-6
- Boc-D-N-Me-Phe.DCHA
Catalog No.:BCC3347
CAS No.:102185-45-5
- PPNDS
Catalog No.:BCC7015
CAS No.:1021868-77-8
Two new steroidal saponins from the rhizomes of Dioscorea panthaica and their cytotoxic activity.[Pubmed:11745024]
Planta Med. 2001 Dec;67(9):853-7.
Two new steroidal saponins, dioscoresides C (1) and D (2), along with a new natural product, pregnadienolone 3-O-beta-gracillimatriose (3), and two known compounds, pregnadienolone 3-O-beta-chacotrioside (4) and Pseudoprotodioscin (5), were isolated from the rhizomes of Dioscorea panthaica Prain et Burkill. On the basis of extensive NMR studies and chemical evidence, dioscoresides C and D were determined to be 26-O-beta-D-glucopyranosyl-3 beta,26-dihydroxy-23(S)-methoxy-25(R)-furosta-5,20(22)-dien-3-O-alpha-L-rhamnopyr anosyl-(1-->2)-[alpha-L-rhamnopyranosyl-(1-->4)]-beta-D-glucopyranoside and 26-O-beta-D-glucopyranosyl-3 beta,26-dihydroxy-20,22-seco-25(R)-furosta-5-en-20,22-dine-3-O-alpha-L-rhamnopyra nosyl-(1-->2)-[alpha-L-rhamnopyranosyl-(1--> 4)]-beta-D-glucopyranoside. These compounds showed mild cytotoxicity against the cancer cell lines, A375, L929, and HeLa, in a dose-dependent manner.
Anti-inflammatory and anti-melanogenic steroidal saponin glycosides from Fenugreek (Trigonella foenum-graecum L.) seeds.[Pubmed:20979021]
Planta Med. 2011 May;77(7):705-10.
Fenugreek seed ( Trigonella foenum-graecum L.) is used as an herbal medicine for treating metabolic and nutritive dysfunctions. To determine if this plant has other beneficial effects, we tested the inhibitory activities of a methanol (MeOH) extract of fenugreek seed on the production of inflammatory cytokines and melanin synthesis in cultured cell lines in vitro. The MeOH extract inhibited the production of phorbol-12-myristate-13-acetate-induced inflammatory cytokines such as tumor necrosis factor (TNF)-alpha in cultured THP-1 cells, and also restrained the intracellular synthesis of melanin in murine melanoma B16F1 cells. We isolated three active constituents from fenugreek seed extracts. These were identified as the steroidal saponins 26- O-beta-D-glucopyranosyl-(25 R)-furost-5(6)-en-3 beta,22 beta,26-triol-3- O-alpha-L-rhamno-pyranosyl-(1'' --> 2')-O-[beta-D-glucopyranosyl-(1''' --> 6')- O]-beta-D-glucopyranoside 1, minutoside B 2, and Pseudoprotodioscin 3. Compounds 1 and 2 strongly suppressed the production of inflammatory cytokines, whereas 3 showed a weaker suppressing effect. Melanogenesis in B16F1 cells was significantly suppressed by 1 and 3, and weakly suppressed by 2. All three compounds showed moderate cytotoxicities. These results indicate that fenugreek extract and its active constituents could protect against skin damage.
